10 Days Left — Early Bird Registration for BiOPartnering Closing Soon

BiOPartnering, taking place during BIOCHINA, is designed as a high-efficiency deal-making platform for the biopharmaceutical industry. Through carefully curated 1V1 meetings, participants can connect directly with decision-makers from multinational corporations, pharma leaders, leading biotech companies, investment firms, and key solution providers. Every meeting is aligned around clear business development, licensing, and investment objectives.

BIOCHINA 2026 will take place in Suzhou, China, in March 2026, bringing together a strong delegation of international pharmaceutical leaders. Leading Big Pharma companies, including Bayer, Eli Lilly, Pfizer, Novartis, BMS, Hikma, Dr. Reddy’s, and others, have confirmed their participation. These companies are forming dedicated teams to actively source innovation projects from China, spanning biologics, innovative drugs, and enabling technologies.

Key benefits of participating in BiOPartnering include:

Pre-matched, goal-driven 1V1 meetings to maximize efficiency

Direct access to C-level executives and BD decision-makers

Accelerated pathways to licensing deals and strategic partnerships

Early Bird Registration ends on December 31. Secure your spot here: https://u.morebio.cn/muyuqmLG

For promo code registration, contact: biochina@enmore.com

Learn more about BiOPartnering: https://lnkd.in/gVXM-Mxj

Limited meeting slots are available, making early registration essential to ensure participation.